October 19, 2014- Interviewed by Steven E. Greer, MD
Did you know that one out of three Americans think that they are “gluten intolerant”. Of those 100 Million people, only 13 Million really have a medical problem caused by gluten.
Alessio Fasano, MD, director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children, is the man who started all of the gluten hype back in 2003 with a paper in the Archives of Internal Medicine. Hoping to reduce some of the current “gluten hysteria,” he has written a book explaining what gluten is, who can and can’t eat it, and why. We interviewed him.
Book reviews, Diabetes, Gastroenterology/Hepatology, Harvard affiliates, Internal medicine, Internal medicine/microbiology immunology, NEJM, Nutrition, Pediatrics, Policy | apples49 | 
June 4, 2015 12:39 pm | 
Comments (0)
May 31, 2015- By Steven E. Greer, MD
I was watching Green Day give their Rock and Roll Hall of Fame acceptance speech and the singer made some references to smoking pot, as if it was his generation’s thing. I have wondered to myself Read more »
January 14, 2015- Interviewed by Steven E. Greer, MD
We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at Read more »
Cedars Sinai LA, Diabetes, Endocrinology, FDA, Gastroenterology/Hepatology, Internal medicine, Neurology, OBGYN, Oncology, Pediatrics, Policy, Preventive Medicine | apples49 | March 19, 2015 4:24 pm | Comments (0)
February 2, 2015- By Steven E. Greer, MD
People have asked me my opinion of the Republican field for 2016 and I have told them that Dr. Rand Paul seems pretty electable now, but my experience tells me that he will let rip a great gaffe soon exposing his Read more »
July 2, 2014- Interviewed by Steven E. Greer, MD
The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” being developed by engineers at Boston University and medical doctors at Massachusetts General hospital. We interviewed Ed Damiano, PhD, the lead biomedical engineer, and Steven Russell, MD PhD, the lead endocrinologist. In Part 1, they review the clinical data.
The research was funded by the NIH and not a medical device or drug company. The researchers selected the components based on merit. They chose the Dexcom G4 Platinum continuous glucose sensor and a Tandem Diabetes t:slim pump, and used software that ran on a standard Apple iPhone 4S.
In Part 2, the team discusses the details of the pivotal study, that could be concluded by 2016, allowing for an FDA approval by 2017. Industry partners yet to be determined would be involved. However, the final marketed product will not require any particular smartphone to be used by the patient.
Boston University, Diabetes, Endocrinology, FDA, Harvard affiliates, Internal medicine, Medical Devices, NEJM, NIH, Nutrition, Pediatrics, Preventive Medicine, Wound Care | apples49 | January 16, 2015 10:36 pm | Comments (0)
November 3, 2014- Interviewed by Steven E. Greer, MD
Inhaled insulin will make a comeback when Read more »
More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage and young adult years. Now, with the other member of the legendary rock band The Who, Pete Townshend, they have formed the UCLA Daltrey/Townshend cancer center and are planning more in the united states. We had the honor to be granted a rare interview with Mr. Daltrey.
October 31, 2014- Interviewed by Steven E. Greer, MD
Type 1 diabetes patients using continuous glucose monitors have been creating their own software, or hacking, to allow their CGM to send the data to a more manageable smartphone. This allows parents and other parties to monitor the health of loved ones, as well as makes the data more easily available to see on Read more »
October 31, 2014- Interviewed by Steven E. Greer, MD
The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM) are still far less than 50%. We interviewed the CEO of Dexcom, Terry Gregg, with diabetes expert Jay Skyler, MD, from Miami, to discuss the clinical hurdles to prescribing CGM.
Disclaimer: Dr. Skyler has various relationships with Dexcom.
